Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs CERo Therapeutics Holdings, Inc. (CERO)
- Biodexa Pharmaceuticals PLC Unsponsored ADR BDRX 0.46 +6.98%
- CERo Therapeutics Holdings, Inc. CERO 0.01 0.00%
Biodexa Pharmaceuticals PLC Unsponsored ADR and CERo Therapeutics Holdings, Inc. are both Biotechnology companies. Biodexa Pharmaceuticals PLC Unsponsored ADR is the larger, with a market value of $440.0K against $140.0K — 3.1× the size. Biodexa Pharmaceuticals PLC Unsponsored ADR has negative trailing earnings, so its P/E is not meaningful; CERo Therapeutics Holdings, Inc. trades at 0.0×. CERo Therapeutics Holdings, Inc. has the higher net margin (0.00% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, CERo Therapeutics Holdings, Inc. leads on 6 and Biodexa Pharmaceuticals PLC Unsponsored ADR on 3.
Valuation
Profitability
| Metric | BDRX | CERO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (1,155.70%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 453.76% | (56.36%) |
| Return on assets | 0.00% | (2,352.32%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack